Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of AR044854A1publicationCriticalpatent/AR044854A1/en
Derivados de imidazopiridinas que inhiben la secreción de ácido gástrico estimulada exógena o endógenamente. Se pueden utilizar en la prevención y tratamiento de enfermedades relacionadas con el ácido gástrico y enfermedades inflamatorias gastrointestinales. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable de dicho compuesto.Imidazopyridine derivatives that inhibit the secretion of gastric acid stimulated exogenously or endogenously. They can be used in the prevention and treatment of diseases related to gastric acid and gastrointestinal inflammatory diseases. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt of said compound.